|
|
Substance Name: Arbekacin sulfate [JAN]
RN: 104931-87-5
UNII: G7395HZ992
InChIKey: UTUVRPOLEMRKQC-XDJMXTNXSA-N
Classification Codes
- Drug / Therapeutic Agent
- Reproductive Effect
Molecular Formula
- C22-H44-N6-O10.x-H2-O4-S
Molecular Weight
- 650.699
* denotes mobile formatted website
Links to Resources
NLM Resources (File Locators)
Other Resources (Internet Locators)
Search for this InChIKey on the Web
Names and Synonyms
Name of Substance
- Arbekacin sulfate [JAN]
- Habekacin
Synonyms
- Arbekacin sulfate
- Habekacin
- NPC-14
- UNII-G7395HZ992
Systematic Name
- D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(2,6-diamino-2,3,4,6-tetradeoxy-alpha-D-erythro-hexopyranosyl-(1-4))-N'-(4-amino-2-hydroxy-1-oxobutyl)-2-deoxy-, (S)-, sulfate (salt)
Registry Numbers
CAS Registry Number
- 104931-87-5
FDA UNII
- G7395HZ992
System Generated Number
- 0104931875
Molecular Formulas
Molecular Formula
- C22-H44-N6-O10.x-H2-O4-S
Molecular Formula Fragments
- C22-H44-N6-O10
- COMPONENT
- H2-O4-S
Structure Descriptors
InChI
InChI=1S/C22H44N6O10.H2O4S/c23-4-3-12(30)20(34)28-11-5-10(26)18(37-21-9(25)2-1-8(6-24)35-21)17(33)19(11)38-22-16(32)14(27)15(31)13(7-29)36-22;1-5(2,3)4/h8-19,21-22,29-33H,1-7,23-27H2,(H,28,34);(H2,1,2,3,4)/t8-,9+,10-,11+,12-,13+,14-,15+,16+,17-,18+,19-,21+,22+;/m0./s1InChIKey
UTUVRPOLEMRKQC-XDJMXTNXSA-NSmiles
NCC[C@H](O)Toxicity
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LDLo | intramuscular | 400mg/kg (400mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: ATAXIA | Kiso to Rinsho. Clinical Report. Vol. 20, Pg. 7587, 1986. |
dog | LDLo | intravenous | 150mg/kg (150mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) | Kiso to Rinsho. Clinical Report. Vol. 20, Pg. 7587, 1986. |
mouse | LD50 | intramuscular | 372mg/kg (372mg/kg) | BEHAVIORAL: AGGRESSION LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 20, Pg. 7473, 1986. |
mouse | LD50 | intraperitoneal | 540mg/kg (540mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: AGGRESSION LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Kiso to Rinsho. Clinical Report. Vol. 20, Pg. 7473, 1986. |
mouse | LD50 | intravenous | 82300ug/kg (82.3mg/kg) | BEHAVIORAL: AGGRESSION LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Kiso to Rinsho. Clinical Report. Vol. 20, Pg. 7473, 1986. |
mouse | LD50 | oral | > 5gm/kg (5000mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 20, Pg. 7473, 1986. | |
mouse | LD50 | subcutaneous | 476mg/kg (476mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: AGGRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) | Kiso to Rinsho. Clinical Report. Vol. 20, Pg. 7473, 1986. |
rat | LD50 | intramuscular | 621mg/kg (621mg/kg) | LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: AGGRESSION LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION | Kiso to Rinsho. Clinical Report. Vol. 20, Pg. 7473, 1986. |
rat | LD50 | intraperitoneal | 588mg/kg (588mg/kg) | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 41, Pg. 2221, 1999. | |
rat | LD50 | intravenous | 150mg/kg (150mg/kg) | LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION LUNGS, THORAX, OR RESPIRATION: CYANOSIS BEHAVIORAL: AGGRESSION | Kiso to Rinsho. Clinical Report. Vol. 20, Pg. 7473, 1986. |
rat | LD50 | oral | > 5gm/kg (5000mg/kg) | Kiso to Rinsho. Clinical Report. Vol. 20, Pg. 7473, 1986. |